{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:10:35Z","timestamp":1793135435519,"version":"4.5.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000046","name":"Abbott Fund","doi-asserted-by":"publisher","award":["2011\u20132020"],"award-info":[{"award-number":["2011\u20132020"]}],"id":[{"id":"10.13039\/100000046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","award":["2009\u20132018"],"award-info":[{"award-number":["2009\u20132018"]}],"id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["2014\u20132021"],"award-info":[{"award-number":["2014\u20132021"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","award":["2009\u20132018"],"award-info":[{"award-number":["2009\u20132018"]}],"id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["2009\u20132019"],"award-info":[{"award-number":["2009\u20132019"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","award":["2009\u20132012"],"award-info":[{"award-number":["2009\u20132012"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pfizer Alliance","award":["2011\u20132019"],"award-info":[{"award-number":["2011\u20132019"]}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","award":["2016\u20132019"],"award-info":[{"award-number":["2016\u20132019"]}],"id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003358","name":"Gedeon Richter","doi-asserted-by":"publisher","award":["2014\u20132016"],"award-info":[{"award-number":["2014\u20132016"]}],"id":[{"id":"10.13039\/501100003358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014337","name":"Menarini Group","doi-asserted-by":"publisher","award":["2009\u20132012"],"award-info":[{"award-number":["2009\u20132012"]}],"id":[{"id":"10.13039\/501100014337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["2011\u20132014"],"award-info":[{"award-number":["2011\u20132014"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","award":["2014\u20132020"],"award-info":[{"award-number":["2014\u20132020"]}],"id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003305","name":"ResMed Foundation","doi-asserted-by":"publisher","award":["2014\u20132016"],"award-info":[{"award-number":["2014\u20132016"]}],"id":[{"id":"10.13039\/100003305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["2009\u20132011"],"award-info":[{"award-number":["2009\u20132011"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","award":["2009\u20132021"],"award-info":[{"award-number":["2009\u20132021"]}],"id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","award":["2019\u20132022"],"award-info":[{"award-number":["2019\u20132022"]}],"id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Diabetes mellitus (diabetes) is common amongst patients with non-ST-segment elevation myocardial infarction (NSTEMI). We describe presentation, care, and outcomes of patients admitted with NSTEMI by diabetes status.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Prospective cohort study including 2928 patients (1104 with prior diabetes, 1824 without) admitted to hospital with NSTEMI from 287 centres in 59 countries. Quality of care was evaluated based on 12 guideline-recommended care interventions. Outcomes included in-hospital acute heart failure, cardiogenic shock, repeat myocardial infarction, stroke\/transient ischaemic attack (TIA), BARC Type\u00a0\u2265\u00a03 bleeding and death, as well as 30-day mortality. Patients with diabetes had higher comorbidity burden and more frequently presented with Killip Class II\u2013IV heart failure (10.2%\u00a0vs. 3.7%, P\u00a0&amp;lt;\u00a00.001), haemodynamic instability (7.1%\u00a0vs. 3.7%, P\u00a0&amp;lt;\u00a00.001), and ongoing chest pain (43.1%\u00a0vs. 37.0%, P\u00a0&amp;lt;\u00a00.001), than those without diabetes. Overall, care quality received was similar by diabetes status (60.0%\u00a0vs. 60.5% received\u00a0\u2265\u00a080% of eligible care interventions, P\u00a0=\u00a00.786), but patients with diabetes experienced higher rates of in-hospital acute heart failure (15.3%\u00a0vs. 6.8% P\u00a0&amp;lt;\u00a00.001), cardiogenic shock (4.5% vs. 2.5%, P\u00a0=\u00a00.002), stroke\/TIA (2.0%\u00a0vs. 0.8%, P\u00a0=\u00a00.006), and death (2.5%\u00a0vs. 1.4%, P\u00a0=\u00a00.022), and higher 30-day mortality (3.3%\u00a0vs. 2.0%, P\u00a0=\u00a00.025). Of NSTEMI with diabetes, only 1.9% and 9.0% received prescription for glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors, respectively, on discharge, and only 45.9% were referred for cardiac rehabilitation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>NSTEMI patients with diabetes, compared with those without, present more clinically unwell and have worse outcomes despite receiving equal quality of care. Prescription of cardiovascular-protective glycaemic agents is an actionable target to reduce risk of further events.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjqcco\/qcae002","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T05:15:57Z","timestamp":1704777357000},"page":"709-722","source":"Crossref","is-referenced-by-count":7,"title":["Diabetes mellitus and presentation, care and outcomes of patients with NSTEMI: the Association for Acute Cardiovascular Care-European Association of Percutaneous Cardiovascular Interventions EURObservational Research Programme NSTEMI Registry of the European Society of Cardiology"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9895-9356","authenticated-orcid":false,"given":"Ramesh","family":"Nadarajah","sequence":"first","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds ,","place":["UK"]},{"name":"Leeds Institute of Data Analytics, University of Leeds ,","place":["UK"]},{"name":"Department of Cardiology, Leeds Teaching Hospitals NHS Trust , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7237-0946","authenticated-orcid":false,"given":"Peter","family":"Ludman","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Laroche","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme, European Society of Cardiology, European Heart House , 2035 Route des Colles, Sophia Antipolis ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-7105","authenticated-orcid":false,"given":"Yolande","family":"Appelman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Center, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5845-1435","authenticated-orcid":false,"given":"Salvatore","family":"Brugaletta","sequence":"additional","affiliation":[{"name":"Hospital Clinic de Barcelona , Barcelona ,","place":["Spain"]},{"name":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6395-2098","authenticated-orcid":false,"given":"Andrzej","family":"Budaj","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center of Postgraduate Medical Education, Grochowski Hospital , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Bueno","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario 12 de Octubre and Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12) , Madrid ,","place":["Spain"]},{"name":"Centro Nacional de Investigaciones Cardiovasculares (CNIC) , Madrid ,","place":["Spain"]},{"name":"Facultad de Medicina, Universidad Complutense de Madrid , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-5524","authenticated-orcid":false,"given":"Kurt","family":"Huber","sequence":"additional","affiliation":[{"name":"3rd Medical Department, Cardiology and Intensive Care Medicine, Clinic Ottakring (Wilhelminenhospital) , Vienna ,","place":["Austria"]},{"name":"Sigmund Freud University, Medical Faculty , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2975-6971","authenticated-orcid":false,"given":"Vijay","family":"Kunadian","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University , Newcastle upon Tyne ,","place":["UK"]},{"name":"Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2447-7685","authenticated-orcid":false,"given":"Sergio","family":"Leonardi","sequence":"additional","affiliation":[{"name":"University of Pavia , Pavia ,","place":["Italy"]},{"name":"Fondazione IRCCS Policlinico\u00a0San Matteo , Pavia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0146-9196","authenticated-orcid":false,"given":"Maddalena","family":"Lettino","sequence":"additional","affiliation":[{"name":"Cardio-Thoracic and Vascular Department , IRCCS San Gerardo dei Tintori Foundation, Monza ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-5147","authenticated-orcid":false,"given":"Dejan","family":"Milasinovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Clinical Center of Serbia and Faculty of Medicine, University of Begrade , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1636-3725","authenticated-orcid":false,"given":"Ramzi","family":"Ajjan","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6141-634X","authenticated-orcid":false,"given":"Nikolaus","family":"Marx","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Cardiology, RWTH Aachen University , Aachen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P","family":"Gale","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds ,","place":["UK"]},{"name":"Leeds Institute of Data Analytics, University of Leeds ,","place":["UK"]},{"name":"Department of Cardiology, Leeds Teaching Hospitals NHS Trust , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"2024121909364426600_bib1","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"2024121909364426600_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2213-8587(21)00327-2","article-title":"Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data","volume":"10","author":"Magliano","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024121909364426600_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.amjcard.2009.10.048","article-title":"Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)","volume":"105","author":"Krempf","year":"2010","journal-title":"Am J Cardiol"},{"key":"2024121909364426600_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European Society of Cardiology: cardiovascular disease statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur Heart J"},{"key":"2024121909364426600_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjmed.2010.07.023","article-title":"Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI","volume":"124","author":"McManus","year":"2011","journal-title":"Am J Med"},{"key":"2024121909364426600_bib6","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.3390\/jcm10194403","article-title":"Prognosis impact of diabetes in elderly women and men with non-ST elevation acute coronary syndrome","volume":"10","author":"D\u00edez-Villanueva","year":"2021","journal-title":"J Clin Med"},{"key":"2024121909364426600_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0735-1097(97)00118-6","article-title":"Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction","volume":"30","author":"Mak","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2024121909364426600_bib8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/01.CIR.102.9.1014","article-title":"Impact of diabetes on long-term prognosis in patients with unstable angina and non\u2014Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry","volume":"102","author":"Malmberg","year":"2000","journal-title":"Circulation"},{"key":"2024121909364426600_bib9","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"2024121909364426600_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ehjqcco\/qcac067","article-title":"Cohort Profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry","volume":"9","author":"Nadarajah","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2024121909364426600_bib11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.5603\/KP.2015.0243","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"73","author":"Roffi","year":"2015","journal-title":"Kardiologia Polska (Polish Heart Journal)"},{"key":"2024121909364426600_bib12","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024121909364426600_bib13","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2024121909364426600_bib14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/eurheartj\/ehx008","article-title":"Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register","volume":"38","author":"Bebb","year":"2017","journal-title":"Eur Heart J"},{"key":"2024121909364426600_bib15","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"2024121909364426600_bib16","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"key":"2024121909364426600_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"2024121909364426600_bib18","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2337\/dc19-0047","article-title":"Reduced cardio-renal function accounts for most of the in-hospital morbidity and mortality risk among patients with type 2 diabetes undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction","volume":"42","author":"Marenzi","year":"2019","journal-title":"Diabetes Care"},{"key":"2024121909364426600_bib19","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1001\/archinte.164.20.2273","article-title":"Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction","volume":"164","author":"Murcia","year":"2004","journal-title":"Arch Intern Med"},{"key":"2024121909364426600_bib20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2016.10766","article-title":"Association of clinical factors and therapeutic strategies with improvements in survival following non\u2014ST-elevation myocardial infarction, 2003-2013","volume":"316","author":"Hall","year":"2016","journal-title":"JAMA"},{"key":"2024121909364426600_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/jech-2016-207402","article-title":"Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study","volume":"71","author":"Alabas","year":"2017","journal-title":"J Epidemiol Community Health"},{"key":"2024121909364426600_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.33963\/KP.15189","article-title":"Prevalence, characteristics, and prognostic implications of type 2 diabetes in patients with myocardial infarction: the Polish Registry of Acute Coronary Syndromes (PL\u2011ACS) annual 2018 report","volume":"78","author":"Niedziela","year":"2020","journal-title":"Kardiologia Polska (Polish Heart Journal)"},{"key":"2024121909364426600_bib23","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2024121909364426600_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2021.12.028","article-title":"Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: the cardio CHUS-HUSJ registry","volume":"351","author":"Ferrero","year":"2022","journal-title":"Int J Cardiol"},{"key":"2024121909364426600_bib25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1532-5415.2007.01589.x","article-title":"Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study","volume":"56","author":"Schoenenberger","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"2024121909364426600_bib26","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/eurheartj\/ehu039","article-title":"The association between older age and receipt of care and outcomes in patients with acute coronary syndromes: a cohort study of the Myocardial Ischaemia National Audit Project (MINAP)","volume":"35","author":"Zaman","year":"2014","journal-title":"Eur Heart J"},{"key":"2024121909364426600_bib27","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1093\/eurheartj\/ehab342","article-title":"Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology","volume":"42","author":"Zeymer","year":"2021","journal-title":"Eur Heart J"},{"key":"2024121909364426600_bib28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/ehjqcco\/qcad008","article-title":"Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology","volume":"9","author":"Nadarajah","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2024121909364426600_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diacare.27.3.699","article-title":"Heart failure prevalence, incidence, and mortality in the elderly with diabetes","volume":"27","author":"Bertoni","year":"2004","journal-title":"Diabetes Care"},{"key":"2024121909364426600_bib30","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1007\/s00125-012-2579-0","article-title":"High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes","volume":"55","author":"Boonman-de Winter","year":"2012","journal-title":"Diabetologia"},{"key":"2024121909364426600_bib31","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.3390\/ijms23073587","article-title":"Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus","volume":"23","author":"Nakamura","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2024121909364426600_bib32","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2003.12.026","article-title":"Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus","volume":"93","author":"Boyer","year":"2004","journal-title":"Am J Cardiol"},{"key":"2024121909364426600_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: incidence and predictors","volume":"8","author":"Jen\u010da","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2024121909364426600_bib34","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2024121909364426600_bib35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"Lancet North Am Ed"},{"key":"2024121909364426600_bib36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2337\/dc19-2165","article-title":"Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease\u2014a persistent challenge in need of substantial improvement: a report from ESC EORP EUROASPIRE V","volume":"43","author":"Ferrannini","year":"2020","journal-title":"Diabetes Care"},{"key":"2024121909364426600_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"2024121909364426600_bib38","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2024121909364426600_bib39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijcard.2014.04.270","article-title":"International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: the MINAP\/NICOR, SWEDEHEART\/RIKS-HIA, and ACTION Registry-GWTG\/NCDR registries","volume":"175","author":"McNamara","year":"2014","journal-title":"Int J Cardiol"},{"key":"2024121909364426600_bib40","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/2047487320913379","article-title":"Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology","volume":"28","author":"Ambrosetti","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2024121909364426600_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Group","year":"2013","journal-title":"N Engl J Med"},{"key":"2024121909364426600_bib42","doi-asserted-by":"crossref","first-page":"10656","DOI":"10.1038\/s41598-022-14603-1","article-title":"Effects of exercise initiation and smoking cessation after new-onset type 2 diabetes mellitus on risk of mortality and cardiovascular outcomes","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"2024121909364426600_bib43","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Collaboration ERF","year":"2010","journal-title":"Lancet North Am Ed"},{"key":"2024121909364426600_bib44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.carrev.2023.02.008","article-title":"Association of diabetes mellitus and its types with in-hospital management and outcomes of patients with acute myocardial infarction","volume":"52","author":"Sethupathi","year":"2023","journal-title":"Cardiovasc Revasc Med"},{"key":"2024121909364426600_bib45","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1093\/eurheartj\/ehac227","article-title":"The collateral damage of COVID-19 to cardiovascular services: a meta-analysis","volume":"43","author":"Nadarajah","year":"2022","journal-title":"Eur Heart J"},{"key":"2024121909364426600_bib46","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/2047487314561876","article-title":"Secondary prevention after acute myocardial infarction: drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry","volume":"22","author":"Urbinati","year":"2015","journal-title":"Eur J Prev Cardiol"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcae002\/56173115\/qcae002.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/10\/8\/709\/56173115\/qcae002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/10\/8\/709\/56173115\/qcae002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T09:37:03Z","timestamp":1734601023000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article\/10\/8\/709\/7513172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,1,8]]},"published-print":{"date-parts":[[2024,12,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcae002","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,1,8]]}}}